Currently, we stand in a great moment of drug development for achondroplasia with one drug in clinical trial, that just started phase 3 (Vosoritide) and another one, the TA-46, that maybe will start clinical trial phase 1 soon. And there … Continue reading
January 26, 2017
by inesp.alves
2 Comments